theMednetRegister

Adult Congenital Heart Disease   

Questions discussed in this category

Would you consider sotalol to be a suitable non-selective beta blocker for primary prevention of variceal bleeding in a patient who requires sotalol for treatment of arrhythmia in the setting of Fontan-associated liver disease and clinically significant portal hypertension?
1 Answer available
In patients with Tetralogy of Fallot and an indication for primary prevention ICD (NSVT, induced VT during EPS, or Low LVEF), should pulmonary valve interventions be offered PRIOR to ICD to assess if improvement in VT burden/EF?
1 Answer available
When would you consider genetic screening of first-degree relatives in patients with bicuspid aortic valves?
2 Answers available
What are first-line choices for vasopressors/inotropes to use in hypotensive patients with Eisenmenger Syndrome?
1 Answer available
How do you manage asymptomatic non-sustained atrial arrhythmia in patients with single ventricle and Fontan physiology?
1 Answer available
What are your top takeaways from ACC 2024?
3 Answers available
When would be the appropriate time to refer an asymptomatic young adult with unicuspid AV s/p valvuloplasty during adolescence for AVR following exercise stress TTE findings demonstrating increase in aortic valve mean gradient from 40mmHg to 70mmHg (achieving 15 METS)?
2 Answers available
Are there any indications to close a PFO during pregnancy if a woman had a cryptogenic stroke in her first trimester?
1 Answer available
What are your top takeaways from AHA 2023?
4 Answers available
What are high-risk clinical and echocardiographic features in pregnant patients with congenital heart disease?
1 Answer available
How do you counsel high-risk women with congenital heart disease who are looking to conceive?
1 Answer available


Papers discussed in this category

Eur Heart J,
2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy.
Circulation, 2020 Dec 17
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
Circulation, 2023 Nov 13
Sudden Cardiac Death in National Collegiate Athletic Association Athletes: A 20-Year Study.
Circulation, 2023 Nov 11
Arrhythmic Risk In Biventricular Pacing Compared with Left Bundle Branch Area Pacing: Results From The International LBBAP Collaborative Study (I-CLAS).
Circulation. Cardiovascular quality and outcomes, 2023 Nov 06
Off-Label Dosing of Direct Oral Anticoagulants Among Inpatients with Atrial Fibrillation in the United States.
American heart journal, 2017 Apr 24
Rationale and design of the Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation (ARTESiA) trial.
The New England journal of medicine, 2023 Nov 11
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes.
American heart journal, 2023 Mar 25
Screening for peripartum cardiomyopathies using artificial intelligence in Nigeria (SPEC-AI Nigeria): Clinical trial rationale and design.
JAMA, 2023 Nov 11
Aspirin and Hemocompatibility Events With a Left Ventricular Assist Device in Advanced Heart Failure: The ARIES-HM3 Randomized Clinical Trial.
Journal of the American College of Cardiology, 2023 May 30
Improved Outcomes After Pulmonary Valve Replacement in Repaired Tetralogy of Fallot.
American heart journal, 2020 Oct 13
Rationale and design of ApoA-I Event Reducing in Ischemic Syndromes II (AEGIS-II): A phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to investigate the efficacy and safety of CSL112 in subjects after acute myocardial infarction.
The New England journal of medicine, 2024 Apr 07
Microaxial Flow Pump or Standard Care in Infarct-Related Cardiogenic Shock.
Circulation, 2016-12-13
Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Apolipoprotein A-I, After Acute Myocardial Infarction: The AEGIS-I Trial (ApoA-I Event Reducing in Ischemic Syndromes I).
American heart journal, 2022 May 17
Empagliflozin in patients post myocardial infarction rationale and design of the EMPACT-MI trial.
The New England journal of medicine, 2024 Apr 06
Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes.
The American journal of cardiology, 2015-12-15
Frequent Atrial Premature Complexes and Their Association With Risk of Atrial Fibrillation.
Congenital heart disease, 2019-05
Extended cardiac ambulatory rhythm monitoring in adults with congenital heart disease: Arrhythmia detection and impact of extended monitoring.
Open heart, 2019
Non-vitamin K antagonist oral anticoagulants in adults with a Fontan circulation: are they safe.
Lancet, 2021 Aug 27
Implantable loop recorder detection of atrial fibrillation to prevent stroke (The LOOP Study): a randomised controlled trial.
Cardiovasc Drugs Ther, 2022 Jan 13
A Multisite Retrospective Review of Direct Oral Anticoagulants Compared to Warfarin in Adult Fontan Patients.
The Canadian journal of cardiology, 2014 Oct
PACES/HRS expert consensus statement on the recognition and management of arrhythmias in adult congenital heart disease: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology (ACC), the American Heart Association (AHA), the European Heart Rhythm Association (EHRA), the Canadian Heart Rhythm Society (CHRS), and the International Society for Adult Congenital Heart Disease (ISACHD).
The New England journal of medicine, 2023 Aug 25
Anticoagulation with Edoxaban in Patients with Atrial High-Rate Episodes.
The New England journal of medicine, 2023 Nov 12
Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation.
Heart rhythm, 2016 Feb 02
The association between influenza infection, vaccination, and atrial fibrillation: A nationwide case-control study.
The Journal of innovations in cardiac rhythm management, 2018 Mar 15
Atrial Antitachycardia Pacing in Complex Congenital Heart Disease: A Case Series.
Frontiers in endocrinology, 2022 Aug 11
Effects of GLP-1 receptor agonists on arrhythmias and its subtypes in patients with type 2 diabetes: A systematic review and meta-analysis.
Journal of the American Heart Association, 2021 Aug 28
Sodium-Glucose Co-Transporter Inhibitors and Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Texas Heart Institute journal, 2024 Apr 30
Dronedarone for the Treatment of Atrial Arrhythmias in Adults With Congenital Heart Disease.
Lancet (London, England), 2019 Mar 22
β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial.

Related Topics

Copyright © 2024 theMednet
All Rights Reserved.